PL
PL · PL · PL-100506006
Vyloy
ATC L01FX
Last synced from URPL (Poland) on
Identification
ManufacturerAstellas Pharma Europe B.V.
CountryPL (PL)
ATC codeL01FX
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 2
- gtin05909991558932
- gtin05909991558925
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Proszek do sporządzania koncentratu roztworu do infuzji",
"source": "urpl",
"strength": "100 mg",
"packaging": "05909991558932 ¦ Rpz ¦ EU/1/24/1856/001 ¦ 158264\n1 fiol. \n05909991558925 ¦ Rpz ¦ EU/1/24/1856/002 ¦ 158265\n3 fiol.",
"substance": "Zolbetuximab 100 mg",
"common_name": "Zolbetuximab",
"pl_product_id": "100506006",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code L01FX.
- NLColumvi 10 mg concentraat voor oplossing voor infusieRoche Registration GmbH
- NLColumvi 2,5 mg concentraat voor oplossing voor infusieRoche Registration GmbH
- PLDatrowayDaiichi Sankyo Europe GmbH
- PLElrexfioPfizer Europe MA EEIG
- PLIMDYLLTRAAmgen Europe B.V.
- PLIMDYLLTRAAmgen Europe B.V.
- ISLynozyficRegeneron Ireland Designated Activity Company
- ISLynozyficRegeneron Ireland Designated Activity Company
Access this data programmatically
Query Vyloy and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.